Following its recent medical device regulation overhaul, Singapore’s Health Sciences Authority (HSA) is planning to carry out further adjustments to the nation’s medical regulations. At present, there are a number of different notifications that collectively operate to control the importation, sales and marketing of medical products in Singapore.
By mid-2011, the Health Products Act (HPA) will likely be the single source for regulations on medical products, ranging from poisonous items to cosmetics. Currently, the HPA only focuses on cosmetics and medical devices.
Along with this merge, other medical products that currently do not have a risk classification system are also expected to begin incorporating risk classifications.
Medical companies will need to follow these new Singapore regulations to be successful there. Regulations in Singapore are normally strictly enforced.